Large-scale testing (Phase 3)Study completedNCT04176939
What this trial is testing
Test GlaxoSmithKline's (GSK) Herpes Zoster (HZ) Subunit Vaccine's Long-term Immune Response in Previously Vaccinated Kidney Transplant Adults and Then to Test if 2 Additional Doses of the Vaccine Are Safe and Able to Generate an Immune Response
Who this might be right for
Herpes Zoster
GlaxoSmithKline 68